[1]MORICE P，LEARY A，CREUTZBERG C，et al.Endometrial cancer［J］.Lancet，2016，387(10023)：1094-1108.
[2]彭芝兰.子宫内膜癌的规范化治疗［J］.中国癌症防治杂志，2012，4(1)：14-18.
PENG ZL.Standardized treatment of endometrial cancer［J］.Chinese Journal of Oncology Prevention and Treatment，2012，4(1)：14-18.
[3]BACKES C，MEESE E，KELLER A.Specific miRNA disease biomarkers in blood，serum and plasma：Challenges and prospects［J］.Mol Diagn Ther，2016，20(6)：509-518.
[4]American Association for Cancer Research.Cancer in 2019［R/OL］.(2019-09-01)［2020-02-26］.https：//cancerprogressreport.org/Pages/cpr19-cancer-in-2019.aspx.
[5]YONEYAMA K，ISHIBASHI O，KAWASE R，et al.miR-200a，miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma［J］.Anticancer Res，2015，35(3)：1401-1410.
[6]The National Center for Biotechnology Information.MIR200A microRNA 200a［R/OL］.(2020-02-09)［2020-02-26］.https：//www.ncbi.nlm.nih.gov/gene/406983.
[7]SNOWDON J，ZHANG X，CHILDS T，et al.The microRNA-200 family is upregulated in endometrial carcinoma［J］.PLoS One，2011，6(8)：e22828.
[8]SHI W，WANG X，RUAN L，et al.MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression［J］.Pharmazie，2017，72(11)：694-699.
[9]YONEYAMA K，ISHIBASHI O，KAWASE R，et al.miR-200a，miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma［J］.Anticancer Res，2015，35(3)：1401-1410.
[10]WU Q，LU RL，LI JX，et al.MiR-200a and miR-200b target PTEN to regulate the endometrial cancer cell growth in vitro［J］.Asian Pac J Trop Med，2017，10(5)：498-502.
[11]李晓雪，石书婧，易翔.鼻咽癌组织中 miR－200a的表达及意义［J］.山东医药，2015，55(34)：14-15.
LI XX，SHI SJ，YI X.Expression and significance of mir-200a in nasopharyngeal carcinoma［J］.Shandong Medical Journal，2015，55(34)：14-15.
[12]汪建林，戴斌，杨西胜，等.肝癌患者血清中miR-200a的表达及其临床意义［J］.中华临床医师杂志（电子版），2013，7(23)：25-27.
WANG JL，DAI B，YANG XS，et al.Expression and clinical significance of mir-200a in serum of patients with liver cancer［J］.Chin J Clin(Electronic Edition)，2013，7(23)：25-27.
[13]American Association for Cancer Research.Cancer Policy Monitor：October 2019［R/OL］.(2019-09-01)［2020-02-26］.https：//www.aacr.org/professionals/policy-and-advocacy/aacr-cancer-policy-monitor/cancer-policy-monitor-archives/cancer-policy-monitor-oct-8-2019.
[14]DONG Y，SI JW，LI WT，et al.miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas［J］.Int J Clin Exp Pathol，2015，8(3)：2864-2875.
[15]KARIHTALA P，PORVARI K，SOINI Y，et al.Expression levels of microRNAs miR-93 and miR-200a in pancreatic adenocarcinoma with special reference to differentiation and relapse-free survival［J］.Oncology，2019，96(3)：164-170.